Curative Biotech announced that the Canadian Intellectual Property Office has issued a Notice of Allowance for a patent related to treating retinal degeneration. The patent includes 22 allowed claims for a pharmacological target developed by Dr. Kapil Bharti and his team at the National Eye Institute. The patent is expected to formally issue in the coming months.

Read more at Yahoo Finance: Curative Biotech announces Canadian patent allowance